Gastrointestinal cancer refers to malignant conditions of the gastrointestinal (GI) tract and other organs involved in digestion, including the oesophagus, stomach, biliary system, pancreas ...

or metastatic human epidermal growth factor receptor 2 (HER2)–positive biliary tract cancer. A conditional marketing authorization is granted to a medicinal product that fulfills an unmet ...

Table 4. Diagnostic performance of different model used to distinguish between biliary tract cancer and benign biliary diseases. In addition, We also evaluated the impact of incorporating gender and ...

The skeletal system comprises 206 bones and has two main parts: the axial skeleton and the appendicular skeleton. The skeletal system includes your bones, ligaments that attach bone to bone, and ...

“The IST complements our ongoing second-line Phase 2/3 study of tovecimig in patients with biliary tract cancer; importantly, we recently announced that tovecimig met the primary endpoint in our ...

Safety and Activity of Fibroblast Growth Factor Receptor Inhibitors in Advanced Malignancies: A Pooled Analysis of Early-Phase Clinical Trials A comprehensive search of PubMed/MEDLINE and EMBASE was ...

The Biliary Tract Cancers (BTCs) Market is expected to grow at a strong CAGR of ~5.5% during the forecast period 2023-2030. The market is influenced by various factors, including the increasing ...

Jazz Pharma has claimed FDA approval for its HER2-directed bispecific antibody Ziihera as a treatment for biliary tract cancer Eisai has launched its new therapy for biliary tract cancer (BTC ...

Background: Cystic duct carcinoma (CDC) is a rare biliary malignancy with a low incidence and poor prognosis. However, the clinical landscape of the disease has not been clarified and no widely ...